Fresenius SE & Co. KGaA (ETR:FRE)
44.70
+0.20 (0.45%)
Apr 10, 2026, 5:35 PM CET
Fresenius SE & Co. KGaA Revenue
In the year 2025, Fresenius SE & Co. KGaA had annual revenue of 22.87B EUR with 4.19% growth. Fresenius SE & Co. KGaA had revenue of 5.96B in the quarter ending December 31, 2025, with 5.88% growth.
Revenue (ttm)
22.68B
Revenue Growth
+4.34%
P/S Ratio
1.10
Revenue / Employee
147.39K
Employees
178,583
Market Cap
25.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.87B | 919.00M | 4.19% |
| Dec 31, 2024 | 21.95B | 887.00M | 4.21% |
| Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
| Dec 31, 2019 | 35.41B | 1.88B | 5.60% |
| Dec 31, 2018 | 33.53B | -356.00M | -1.05% |
| Dec 31, 2017 | 33.89B | 4.42B | 14.98% |
| Dec 31, 2016 | 29.47B | 1.48B | 5.27% |
| Dec 31, 2015 | 28.00B | 4.54B | 19.34% |
| Dec 31, 2014 | 23.46B | 3.13B | 15.39% |
| Dec 31, 2013 | 20.33B | 823.00M | 4.22% |
| Dec 31, 2012 | 19.51B | 3.15B | 19.23% |
| Dec 31, 2011 | 16.36B | 389.00M | 2.44% |
| Dec 31, 2010 | 15.97B | 1.81B | 12.76% |
| Dec 31, 2009 | 14.16B | 1.81B | 14.66% |
| Dec 31, 2008 | 12.35B | 995.00M | 8.76% |
| Dec 31, 2007 | 11.36B | 581.00M | 5.39% |
| Dec 31, 2006 | 10.78B | 2.89B | 36.61% |
| Dec 31, 2005 | 7.89B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Merck KGaA | 21.10B |
| Fresenius Medical Care AG | 19.63B |
| Sartorius Aktiengesellschaft | 3.54B |
| Drägerwerk AG & Co. KGaA | 3.48B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
Fresenius SE & Co. KGaA News
- 4 days ago - EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 11 days ago - EQS-DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy - Wallstreet:Online
- 11 days ago - EQS-DD: Fresenius SE & Co. KGaA: Robert Möller, buy - Wallstreet:Online
- 26 days ago - EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, buy - Wallstreet:Online
- 27 days ago - Glenmark Pharmaceuticals to launch Potassium Phosphates Injection in March 2026 - Business Upturn
- 1 year ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 1 year ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - WSJ
- 2 years ago - Healthcare group Fresenius tops Q4 operating profit expectations - Reuters